These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Minimal cytological changes of progressive supranuclear palsy type in clinically possible progressive supranuclear palsy. Toru S; Uchihara T; Akashi T; Kobayashi T Eur Neurol; 2010; 63(2):122-5. PubMed ID: 20110714 [No Abstract] [Full Text] [Related]
3. Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene. Rossi G; Gasparoli E; Pasquali C; Di Fede G; Testa D; Albanese A; Bracco F; Tagliavini F Ann Neurol; 2004 Mar; 55(3):448. PubMed ID: 14991829 [No Abstract] [Full Text] [Related]
5. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. Chalmers KA; Love S J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683 [TBL] [Abstract][Full Text] [Related]
7. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Jellinger KA Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518 [TBL] [Abstract][Full Text] [Related]
8. Can mid-sagittal MRI be used to diagnose progressive supranuclear palsy? Reich SG Nat Clin Pract Neurol; 2006 Jan; 2(1):12-3. PubMed ID: 16932511 [No Abstract] [Full Text] [Related]
9. Progressive supranuclear gaze palsy without parkinsonism: a case of neuro-Whipple. Magherini A; Pentore R; Grandi M; Leone ME; Nichelli PF Parkinsonism Relat Disord; 2007 Oct; 13(7):449-52. PubMed ID: 17071126 [TBL] [Abstract][Full Text] [Related]
10. The relationship between histopathological features of progressive supranuclear palsy and disease duration. Josephs KA; Mandrekar JN; Dickson DW Parkinsonism Relat Disord; 2006 Mar; 12(2):109-12. PubMed ID: 16337422 [TBL] [Abstract][Full Text] [Related]
11. Tau gene delN296 mutation, Parkinson's disease, and atypical supranuclear palsy. Oliva R; Pastor P Ann Neurol; 2004 Mar; 55(3):448-9. PubMed ID: 14991828 [No Abstract] [Full Text] [Related]
12. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445 [TBL] [Abstract][Full Text] [Related]
13. Hypertension and progressive supranuclear palsy: is everything so clear? Sibon I; Macia F; Vital A; Delacourte A; Tison F Mov Disord; 2004 Oct; 19(10):1259-61. PubMed ID: 15390036 [No Abstract] [Full Text] [Related]